NKG2D receptor–mediated NK cell function is regulated by inhibitory Ly49 receptors
Open Access
- 1 January 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (1), 233-240
- https://doi.org/10.1182/blood-2004-03-1075
Abstract
Interaction of the activating ligand H60 with NKG2D receptor constitutes a major stimulatory pathway for natural killer (NK) cells. The influence of inhibitory Ly49 receptors on NKG2D-mediated activation is not clearly understood. Here we show that the magnitude of NKG2D-mediated cytotoxicity is directly proportional to both the levels of H60 and the nature of major histocompatibility complex (MHC) class I molecules expressed on the target cells. The expression levels of H60 on the target cells determined the extent to which the inhibition by Ly49C/I receptors can be overridden. In contrast, even a higher expression of H60 molecule on the target cells failed to overcome the inhibition mediated by Ly49A/G receptors. Also, the level of interferon-γ (IFN-γ) and granulocyte-macrophage colony-stimulating factor (GM-CSF) generated by NK cells through anti-NKG2D monoclonal antibody (mAb)-mediated activation is significantly reduced by the presence of immobilized anti-Ly49A/G mAbs. Thus, NKG2D-mediated cytotoxicity and cytokine secretion results from the fine balance between activating and inhibitory receptors, thereby defining the NK cell-mediated immune responses. (Blood. 2005;105:233-240)Keywords
This publication has 47 references indexed in Scilit:
- Slow receptor acquisition by NK cells regenerated in vivo from transplanted fetal liver or adult bone marrow stem cellsExperimental Hematology, 2003
- Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2KbNature Immunology, 2003
- Slow receptor acquisition by NK cells regenerated in vivo from transplanted fetal liver or adult bone marrow stem cellsExperimental Hematology, 2003
- Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activationImmunology, 2003
- A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunityEuropean Journal of Immunology, 2003
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Regulation of Cutaneous Malignancy by γδ T CellsScience, 2001
- Mouse Ly-49A Interrupts Early Signaling Events in Natural Killer Cell Cytotoxicity and Functionally Associates with the SHP-1 Tyrosine PhosphataseThe Journal of Experimental Medicine, 1997
- The Ly-49D Receptor Activates Murine Natural Killer CellsThe Journal of Experimental Medicine, 1996
- The Role of Ly49A and 5E6(Ly49C) Molecules in Hybrid Resistance Mediated by Murine Natural Killer Cells Against Normal T Cell BlastsImmunity, 1996